Actuate Therapeutics, Inc. · NASDAQ:ACTU
Actuate Therapeutics, Inc. shareholders
As of Jun 30, 2026, 62 institutions reported holding Actuate Therapeutics, Inc., 56.3% of its shares. Largest: BIOS Capital Management, LP, Voss Capital, LP and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Actuate Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BIOS Capital Management, LP | 10M | 41.9% | no change | Aug 14, 2026 |
| Voss Capital, LP | 1.73M | 7.2% | no change | Aug 14, 2026 |
| Vanguard | 453K | 1.9% | −15,191 | Aug 13, 2026 |
| AQR Capital Management LLC | 127K | 0.53% | +100K | Aug 14, 2026 |
| Geode Capital | 113K | 0.47% | −116K | Aug 12, 2026 |
| Texas Capital Bank Wealth Management Services Inc | 103K | 0.43% | +8,020 | Aug 7, 2026 |
| Palogic Value Management, L.P. | 100K | 0.42% | no change | Aug 14, 2026 |
| Millennium | 96,684 | 0.40% | new | Aug 14, 2026 |
| BlackRock | 90,035 | 0.37% | −337K | Aug 7, 2026 |
| ABS Investment Management LLC | 73,186 | 0.30% | first report | Aug 14, 2026 |